MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/102.5/0.1/20.09.24 Share Price

Warrant

DE000MG4D2M0

Market Closed - Börse Stuttgart 19:56:51 08/07/2024 BST
0.039 EUR -20.41% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/102.5/0.1/20.09.24
Current month-25.00%
1 month-82.27%
Date Price Change
08/07/24 0.039 -20.41%
05/07/24 0.049 -3.92%
03/07/24 0.051 +2.00%
02/07/24 0.05 -16.67%
01/07/24 0.06 +15.38%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 07:56 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D2M
ISINDE000MG4D2M0
Date issued 16/05/2024
Strike 102.5 $
Maturity 20/09/2024 (74 Days)
Parity 10 : 1
Emission price 0.98
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.02
Lowest since issue 0.034
Spread 0.023
Spread %36.51%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.22 USD
Average target price
83.43 USD
Spread / Average Target
+45.81%
Consensus